Product Images Flovent Hfa

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Flovent Hfa NDC 50090-0934 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

fluticasone propionate chemical structure - floventhfa spl graphic 01

fluticasone propionate chemical structure - floventhfa spl graphic 01

Figure 1. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Inadequately Controlled on Bronchodilators Alone: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 1) - floventhfa spl graphic 02

Figure 1. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Inadequately Controlled on Bronchodilators Alone: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 1) - floventhfa spl graphic 02

Figure 2. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 2) - floventhfa spl graphic 03

Figure 2. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 2) - floventhfa spl graphic 03

The text describes the percentage change in FEV (Forced Expiratory Volume) from baseline for different dosages of FLOVENT HFA and placebo in a study. The dosages tested were 88mcg, 220mcg, and 440mcg twice daily. The results are shown in a graph with the baseline measures taken at day 1 and the endpoint measures taken at days 7 to 12.*

Figure 3. A 16-Week Clinical Trial in Subjects Aged 12 Years and Older Requiring Chronic Oral Prednisone Therapy: Change in Maintenance Prednisone Dose - floventhfa spl graphic 04

Figure 3. A 16-Week Clinical Trial in Subjects Aged 12 Years and Older Requiring Chronic Oral Prednisone Therapy: Change in Maintenance Prednisone Dose - floventhfa spl graphic 04

The text is describing a graph or chart that displays the percentage of subjects with an increase in dose and reduction in dose for two types of medication, "Placebo" and "FLOVENT HFA". The data is presented in percentages, with values ranging from 100% to as low as 3%. The text includes some symbols, such as "%" and "-", as well as some unclear characters.*

Figure A - floventhfa spl graphic 05

Figure A - floventhfa spl graphic 05

This appears to be a description of a metal canister with a dark orange plastic actuator and mouthpiece. It also has a counter peach cap.*

Figure B - floventhfa spl graphic 06

Figure B - floventhfa spl graphic 06

Fgure C - floventhfa spl graphic 07

Fgure C - floventhfa spl graphic 07

Figure D - floventhfa spl graphic 08

Figure D - floventhfa spl graphic 08

Figure E - floventhfa spl graphic 09

Figure E - floventhfa spl graphic 09

The text is describing the position of a mouthpiece in a dark orange color, which appears to be in a "Mouthpiece-Down" position. It might be related to a musical instrument or some other device that requires a mouthpiece.*

Figure F - floventhfa spl graphic 10

Figure F - floventhfa spl graphic 10

This is a simple instruction on how to exhale as much air as possible.*

Figure G - floventhfa spl graphic 11

Figure G - floventhfa spl graphic 11

Figure H - floventhfa spl graphic 12

Figure H - floventhfa spl graphic 12

Figure I - floventhfa spl graphic 13

Figure I - floventhfa spl graphic 13

floventhfa spl graphic 14

floventhfa spl graphic 14

Label Image - lbl500900934

Label Image - lbl500900934

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.